key: cord-0938773-kgedy12a authors: Fuentes, Blanca; Alonso de Leciñana, María; Rigual, Ricardo; García‐Madrona, Sebastián; Díaz‐Otero, Fernando; Aguirre, Clara; Calleja, Patricia; Egido‐Herrero, José A.; Carneado‐Ruiz, Joaquín; Ruiz‐Ares, Gerardo; Rodríguez‐Pardo, Jorge; Rodríguez‐López, Ángela; Ximénez‐Carrillo, Álvaro; de Felipe, Alicia; Ostos, Fernando; González‐Ortega, Guillermo; Simal, Patricia; Gómez Escalonilla, Carlos I.; Gómez‐Porro‐Sánchez, Pablo; Cabal‐Paz, Borja; Reig, Gemma; Gil‐Núñez, Antonio; Masjuán, Jaime; Díez Tejedor, Exuperio title: Fewer COVID‐19‐associated strokes and reduced severity during the second COVID‐19 wave: The Madrid Stroke Network date: 2021-09-27 journal: Eur J Neurol DOI: 10.1111/ene.15112 sha: 514999ff0eefbbda3c0f465dffbd555f6ad01756 doc_id: 938773 cord_uid: kgedy12a BACKGROUND AND PURPOSE: The experience gained during the first COVID‐19 wave could have mitigated the negative impact on stroke care in the following waves. Our aims were to analyze the characteristics and outcomes of patients with stroke admitted during the second COVID‐19 wave and to evaluate the differences in the stroke care provision compared with the first wave. METHODS: This retrospective multicenter cohort study included consecutive stroke patients admitted to any of the seven hospitals with stroke units (SUs) and endovascular treatment facilities in the Madrid Health Region. The characteristics of the stroke patients with or without a COVID‐19 diagnosis were compared and the organizational changes in stroke care between the first wave (25 February to 25 April 2020) and second wave (21 July to 21 November 2020) were analyzed. RESULTS: A total of 550 and 1191 stroke patients were admitted during the first and second COVID‐19 waves, respectively, with an average daily admission rate of nine patients in both waves. During the second wave, there was a decrease in stroke severity (median National Institutes of Health Stroke Scale 5 vs. 6; p = 0.000), in‐hospital strokes (3% vs. 8.1%) and in‐hospital mortality (9.9% vs. 15.9%). Furthermore, fewer patients experienced concurrent COVID‐19 (6.8% vs. 19.1%), and they presented milder COVID‐19 and less severe strokes. Fewer hospitals reported a reduction in the number of SU beds or deployment of SU personnel to COVID‐19 dedicated wards during the second wave. CONCLUSIONS: During the second COVID‐19 wave, fewer stroke patients were diagnosed with COVID‐19, and they had less stroke severity and milder COVID‐19. The first coronavirus disease 2019 (COVID-19) pandemic wave challenged stroke care provision worldwide, with reduced stroke admissions and rates of intravenous thrombolysis (IVT) and mechanical thrombectomy (MT) [1, 2] . This has been partly attributed to the overload of emergency medical systems (EMS) and hospitals with patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with many of the human and material resources usually dedicated to stroke care reallocated to treat patients with COVID-19 [3] . Several expert-based recommendations on stroke care have been released to provide timely and effective care for stroke whilst ensuring stroke teams' safety and minimizing their risk of infection [4] [5] [6] [7] [8] . Therefore, the experience gained during the first COVID-19 wave could have mitigated the negative impact on stroke care in the following pandemic waves. In fact, a recovery in stroke hospitalization volumes was reported in the final period of the first COVID-19 wave [1] , and a smaller decline in hospitalizations occurred during the second wave than during the first compared with two prepandemic periods in Germany [9] . Moreover, it has been reported that strokes experienced by patients infected with SARS-CoV-2 are more severe and had poorer outcomes [10, 11] , but it is possible that the treatment protocols for COVID-19, refined thanks to the results of clinical trials and observational studies conducted during the first wave, together with better organization of stroke care for infected patients, might have resulted in better outcomes. The Madrid Stroke Network provides acute stroke care for approximately 6.5 million inhabitants, and seven hospitals are MTready on a weekly rotation basis, ensuring that three hospitals provide full-time coverage every day. During the first wave of the pandemic, some organizational changes to secure stroke care provision were arranged [12, 13] . Briefly, they included protocols to ensure access to hospital care; measures for the early recognition of COVID-19-positive patients; the organization of specific pathways for infected and non-infected patients; the avoidance of unnecessary diagnostic procedures that could increase the risk of contagion; and early discharge. Our aims were to analyze the characteristics and outcomes of patients with acute stroke admitted during the second COVID-19 wave and to evaluate the differences in stroke care provision compared with the first wave of the pandemic in the Madrid Health Region. A retrospective, multicenter cohort study was conducted that included all consecutive acute stroke patients admitted to any of the seven hospitals equipped with stroke units (SUs) and endovascular treatment facilities in the Madrid Health Region [14] . The number and characteristics of stroke patients with or without a diagnosis of SARS-CoV-2 infection were compared and the organizational changes implemented for stroke care between the first (25 February to 25 April 2020) [10] and second (21 July to 21 November 2020) pandemic waves were recorded. The dates defining the two waves were selected considering the beginning of the rise in the incidence and the flattening of the downward slope of the curve according to the official data on the daily incidence of COVID-19 in the Madrid Health Region [15] . No exclusion criteria, other than stroke mimics, were applied, to ensure the complete capture of all patients with acute stroke admitted to the participating hospitals. Demographic data, risk factors, stroke characteristics and management, workflow metrics (times from onset to arrival, door-toimaging, door-to-needle if IVT, door-to-puncture if MT) and stroke severity (assessed using the National Institutes of Health Stroke Scale [NIHSS] score) were recorded. The time elapsed between stroke and SARS-CoV-2 infection diagnosis, treatment received, chest computed tomography (CT) and laboratory data were recorded, as well as in-hospital complications and modified Rankin Scale score at discharge. Confirmed diagnoses of COVID-19 disease were based on detecting SARS-CoV-2 nucleic acid by polymerase chain reaction (PCR) assay from nasopharyngeal/oropharyngeal swabs or detecting immunoglobulin G (IgG) or IgM serum antibodies in selected patients with high level of suspicion of COVID-19 and a negative PCR test [16, 17] . Given the deficiency of PCR and immunoglobulin assays during the first wave, some patients might have been classified as suspected COVID-19 cases based on their clinical symptoms, blood assessments and chest CT findings [18] . The clinical severity of COVID-19 was classified as mild (mild symptoms), moderate (evidence of lower respiratory disease during clinical assessment or imaging with oxygen saturation [SpO 2 ] ≥94% on room air or with low supplemental oxygen requirements) or severe (high oxygen requirements, non-invasive or invasive ventilation or other cause of intensive care unit admission). Lastly, a survey amongst the SU coordinators from the participating centers was conducted to analyze the organizational changes implemented for stroke care provision during the first and second COVID-19 waves. Questions were focused on changes in infrastructure and resources, stroke code pathways and rehabilitation, and on the provision of educational and research activities. Study data were collected and managed using Research Electronic Data Capture (REDCap) [19] The data recorded during the first and second COVID-19 waves were compared and the differences between the patients with confirmed SARS-CoV-2 infection in both waves were analyzed. The relationship between the COVID-19 diagnoses and stroke outcomes (death or dependence) during the second wave was analyzed using multivariate logistic regression models to adjust for confounders. Temporal trends in stroke admissions were analyzed by the autoregressive integrated moving average. Statistical significance was considered when p values were <0.05. This study was approved by the Ethics Committee of La Paz University Hospital. As a retrospective study, the committee exempted it from the need for patient consent. A total of 550 and 1191 patients with acute stroke were admitted during the first [10] and second COVID-19 waves, with a daily admission rate (median, IQR) of 9 (5) and 9 (4), respectively. Patients admitted during the second wave were more frequently smokers and had a higher frequency of prior stroke, namely prior cerebral infarction (13.7% vs. 8.9%; p = 0.002) ( patients. Interestingly, in contrast to the first wave [10] , the rate of stroke admissions remained stable throughout the second wave. The prehospital stroke code was activated for 47.9% of patients during the second wave, a rate significantly lower than that of the first wave [10] , with a higher proportion of patients arriving at hospital using their own personal transport and no differences in the percentage of secondary transfers. Interestingly, in-hospital strokes significantly decreased during the second wave (Table 1 ). Figure 2 shows the temporal trends in the transport methods for arriving at the hospital during the second wave. There was a slight increase in transfers to hospitals by the EMS throughout the study period, whilst secondary transfers and arrivals by personal transportation remained stable. Overall, stroke severity was lower during the second wave in terms of lower NIHSS score, as were in-hospital mortality and the rate of death or dependence at discharge. The proportions of stroke types in the final diagnosis were similar (Table 1) . During the first COVID-19 wave, there was a reduction in SU beds and neurology ward beds at four and seven hospitals, respectively. The SUs were reallocated to provide semicritical non-stroke care in one hospital, and the neurological ward was moved elsewhere in three hospitals. However, the second wave had a lower impact on stroke care infrastructure, with only one hospital reporting a reduction in SU beds (Figure 4a ). Moreover, neurologists and neurology residents were less frequently reallocated to COVID-19 wards ( Figure 4b ). During the first wave, the availability of 24 h/7 days MT was implemented in all seven hospitals, whilst during the second wave it was not deemed necessary, and the rotatory shift between hospitals was maintained due to reduced EMS overload (Figure 4c ). However, the provision of rehabilitation therapies did not improve from the first to the second wave, with delays in starting physiotherapy in four hospitals and reductions in the number of in-hospital rehabilitation-dedicated beds. Nevertheless, none of the hospitals reported discharging disabled patients to home due to a lack of resources during the second wave, which was a limitation faced by two hospitals during the first wave (Figure 4d) . In fact, a significant increase in the proportion of stroke patients discharged to other hospitals including rehabilitation facilities was found during the second wave, with no significant changes in the discharges to nursing homes ( Table 1) . The COVID-19 pandemic also affected the educational and research activities during the first wave, with a slight improvement during the second wave, although education for medical students remained restricted in all seven hospitals (Figure 4e ). Fewer stroke physicians were on leave due to COVID-19 compared with the first wave ( Figure S1 ). This was a multicenter cohort study aimed at describing the differences in clinical characteristics and outcomes of patients with acute The COVID-19 pandemic changed the clinical profile of patients with acute stroke, with an increased prevalence of younger patients and more severe strokes attributed to large vessel occlusions and higher in-hospital mortality compared with pre-COVID controls [20] . Our study shows no changes in the demographic and risk factor profile between the first two waves, but lower stroke severity and in-hospital mortality in the second wave. Similarly, the characteristics of COVID-19 have changed throughout the pandemic. As previously reported, patients admitted during the second wave presented milder COVID-19 symptoms, less inflammatory analytical profiles and a lower mortality rate, even for COVID-19 pneumoniarelated death [21, 22] . These differences could be related to the increased awareness of patients who consulted before presenting severe symptoms, as well as to a more prepared and experienced health system. Also, there was a change in the therapeutic approach towards more targeted treatment with a more extensive use of corticosteroids, which helped improve outcomes for patients with COVID-19 [23] . One important concern related to the COVID-19 outbreak was its negative impact on acute stroke care, with reported reductions in ischaemic and hemorrhagic stroke hospitalizations, as well as in IVT and MT rates compared with historical controls [1, 2] . A prior report One of the challenges in providing acute stroke care was to ensure protection of stroke care workers against SARS-CoV-2 contagion, and specific recommendations from scientific societies and expert-based consensus on this topic were released [13, [24] [25] [26] [27] . Earlier studies have shown that front-line healthcare workers had a three-fold higher risk of a positive COVID-19 test compared with the general population, even after accounting for other risk factors [28] . This finding might have been associated with the scarcity and reuse of personal protective equipment during the first wave of the pandemic [28] . In our setting, a study from the Stroke Group of the Spanish Society of Neurology reported an 18% rate of medical leaves affecting staff neurologists and 23% of the neurology residents [29] . During the second wave, when protection measures were clearly improved, five of the seven hospitals participating in this study reported a reduction in the proportion of neurologists infected, and only one hospital showed a higher contagion rate compared with the first wave. The limitations of this analysis were that data were not collected on the serological prevalence or infection rates amongst other members of the stroke teams (stroke nurses, neurointerventionalists, rehabilitation physicians and neurology residents). It is not possible to specify whether the stroke neurologists were infected during stroke care, because of their redeployment to attend COVID-19 patients, or due to transmission from coworkers before the universal use of masks [28, 30, 31] . Stroke education for medical students and neurology trainees in our network were negatively impacted by the COVID-19 pandemic in line with other reports [29] , and certain modifications to neurology residence training have been proposed to promote resident safety such as virtual education activities. Also, different approaches have been implemented to rapidly adapt to redeployment, service needs and trainee illness [32] . The number or the extent of the clinical trials or academic studies whose recruitment was delayed or stopped or those that could not be started because of the delayed regulatory or funding approval during the national lockdown was not specifically addressed. However, the negative impact on stroke research has been highlighted as collateral damage of the COVID-19 pandemic [33] . Our results suggest a slight but encouraging improvement in research activities in our setting during the second wave. Our study has several strengths. First, the study was based on vaccines against COVID-19 on the stroke incidence or stroke severity since they were not yet available in Spain during either of the two COVID-19 waves analyzed. In conclusion, during the second COVID-19 wave, fewer patients with stroke were diagnosed with COVID-19, and those that were showed milder stroke and COVID-19 severity. Despite a reduction in in-hospital mortality of patients with COVID-19 and stroke in the second wave, COVID-19 remained significantly associated with poorer stroke outcomes. Learning from experience has helped us maintain a strong stroke care organization, avoiding a reduction in SU beds and reduced reallocation of the SU infrastructure and personnel to COVID-19-dedicated wards. The support of Morote Traducciones for editing assistance is greatly appreciated. Supported by the INVICTUS-Plus Spanish Network of the Carlos III Health Institute (ISCIII) (RD16/0019/0005). None. The data supporting the findings of this study are available from the corresponding author upon request. Global impact of COVID-19 on stroke care and intravenous thrombolysis Global impact of COVID-19 on stroke care Stroke care in Europe during the COVID-19 pandemic Management of acute ischemic stroke in patients with COVID-19 infection: insights from an international panel Protected code stroke: hyperacute stroke management during the coronavirus disease 2019 (COVID-19) pandemic Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations Practice recommendations for the neurovascular ultrasound investigations of acute stroke patients in the setting of COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral Hemodynamics Temporary emergency guidance to US stroke centers during the coronavirus disease 2019 (COVID-19) pandemic A full year of the COVID-19 pandemic with two infection waves and its impact on ischaemic stroke patient care in Germany Stroke acute management and outcomes during the COVID-19 outbreak: a cohort study from the Madrid Stroke Network Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the Global COVID-19 Stroke Registry Impact of the COVID-19 pandemic on the organisation of stroke care Madrid Stroke Care Plan Acute stroke care during the COVID-19 pandemic. Ictus Madrid Program recommendations A collaborative system for endovascular treatment of acute ischaemic stroke: the Madrid Stroke Network experience Casos positivos de Covid-19 notificados por PCR Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19 Variation in false-negative rate of reverse transcriptase polymerase chain reaction-based SARS-CoV-2 tests by time since exposure Updating the diagnostic criteria of COVID-19 The REDCap consortium: building an international community of software platform partners Changes in stroke hospital care during the COVID-19 pandemic: a systematic review and meta-analysis. Stroke First and second COVID-19 waves in Japan: a comparison of disease severity and characteristics First and second waves of coronavirus disease-19: a comparative study in hospitalized patients in Reus Dexamethasone in hospitalized patients with COVID-19 Management of acute ischemic stroke in patients with COVID-19 infection: report of an international panel Practice recommendations for neurovascular ultrasound investigations of acute stroke patients in the setting of the COVID-19 pandemic: an expert consensus from the European Society of Neurosonology and Cerebral Hemodynamics Protected code stroke Preserving stroke care during the COVID-19 pandemic: potential issues and solutions Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study Stroke care during the COVID-19 outbreak in Spain: the experience of Spanish stroke units Update alert 8: epidemiology of and risk factors for coronavirus infection in health care workers Quantification of occupational and community risk factors for SARS-CoV-2 seropositivity among health care workers in a large U.S. health care system Modification to neurology residency training COVID-19 and stroke-understanding the relationship and adapting services. A global World Stroke Organisation perspective Main differences between the first and second waves of COVID-19 in Madrid, Spain Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, populationbased seroepidemiological study